PURELON 1.4 %
Cohesive Ophthalmic Viscosurgical Device (OVD)
Overview
PURELON 1.4% offers the perfect balance between viscosity, clarity, and elasticity, providing surgeons with reliable control during all stages of cataract surgery.
Containing 14 mg/mL sodium hyaluronate produced via biofermentation, it ensures smooth intraocular manipulation, excellent chamber maintenance, and safe IOL placement. It is a versatile cohesive OVD designed for surgeons seeking both ease of injection and consistent space stability.
Technical Specifications
Composition: Sodium Hyaluronate in Phosphate Saline Buffer Colorless, clear, sterile, non-pyrogenic.
HA Concentration: 14 mg/mL (1.4 %)
Molecular Weight: 2.8 – 3.2 Daltons
Classification: Cohesive
Viscosity: 110,000-150,000 mPa·s
pH: 6.8 – 7.6
Osmolality: 280 – 400 mOsm/kg
Storage Temperature: +2 °C to +25 °C
Shelf Life: 36 months
Packaging: 0.55 / 0.85 / 1.0 / 1.5 mL prefilled glass syringe in sterile blister – includes patient labels & IFU
Usage Condition: Ready to use — no pre-cooling required
Key Features
Optimal balance between cohesiveness and control
Ensures long-lasting chamber depth maintenance
Facilitates safe IOL implantation
High optical clarity and easy removal
Sterile, single-use glass syringe
Recommended Use
PURELON 1.4% is recommended for cataract extraction, IOL implantation, and anterior chamber maintenance where balanced viscoelastic performance is required for surgical precision.
Interested in PURELON 1.4 % for your practice?
Contact us to request product details, technical documents, or distributor information.